Published online Feb 6, 2025. doi: 10.12998/wjcc.v13.i4.99637
Revised: September 27, 2024
Accepted: October 29, 2024
Published online: February 6, 2025
Processing time: 111 Days and 14.4 Hours
Kawasaki disease (KD) is a significant pediatric vasculitis known for its potential to cause severe coronary artery complications. Despite the effectiveness of initial treatments, such as intravenous immunoglobulin, KD patients can experience long-term cardiovascular issues, as evidenced by a recent case report of an adult who suffered a ST-segment elevation myocardial infarction due to previous KD in the World Journal of Clinical Cases. This editorial emphasizes the critical need for long-term management and regular surveillance to prevent such complications. By drawing on recent research and case studies, we advocate for a structured approach to follow-up care that includes routine cardiac evaluations and preven
Core Tip: Kawasaki disease management requires ongoing surveillance due to the risk of severe coronary artery complications. Consistent follow-up and preventive care are essential for reducing the risk of adverse cardiovascular events in Kawasaki disease patients.
